Business · 25/03/2019
FDA Hosts Public Workshop to Discuss Development of Antibacterial Drugs for Nontuberculous Mycobacterial Disease
The FDA is hosting a public workshop to discuss the clinical trial design considerations for the development of antibacterial drugs to treat nontuberculous mycobacterial disease, a request for comments from the public on the topic
Original source language: Federal Register — Food and Drug AdministrationOpen original release →